Bridgefront Capital’s Dorman Products DORM Stock Holding History

Bridgefront Capital’s Portfolio DORM Stock Details DORM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,755	Closed	-$332K	–	663
2025 Q1	$332K	Buy	+2,755	New	+$351K	0.1%	371

Other funds holding DORM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Bridgefront Capital's DORM Position: Q2 2025 in Review

Bridgefront Capital sold out of Dorman Products (DORM) in Q2 2025, closing a stake of 2,755 shares — an estimated $332K sold.

Bridgefront Capital first reported a position in DORM in Q1 2025 and held it in 1 quarter. The position peaked at $332K in Q1 2025. 340 funds tracked by Wall St. Rank hold DORM as of Q2 2025.

Bridgefront Capital reported no remaining Dorman Products position as of Q2 2025 after selling out during the quarter.
Bridgefront Capital sold 2,755 Dorman Products shares in Q2 2025, an estimated $332K.
Bridgefront Capital first reported a position in Dorman Products in Q1 2025 and held it in 1 quarter.
Bridgefront Capital's Dorman Products position peaked at $332K in Q1 2025.
340 funds tracked by Wall St. Rank held Dorman Products as of Q2 2025.

Based on Bridgefront Capital's 13F filing for Q2 2025, filed 14 Aug 2025.